Both in Pharmaceuticals
Theriva Biologics vs Moleculin Biotech
Over the past year TOVX returned −40.6% and MBRX returned −96.7%; their daily moves had a correlation of 0.01.
TOVX −40.6% MBRX −96.7%Growth of $1, one year, split-adjusted
| Metric | TOVX | MBRX |
|---|---|---|
| Price | $0.1929 | $8.56 |
| Market cap | $8.9M | $8.7M |
| Today | +5.99% | +3.11% |
| 1 month | −13.1% | −4.0% |
| 6 months | −49.5% | −82.7% |
| Year to date | −8.3% | −87.1% |
| 1 year | −40.6% | −96.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 29.5× | — |
| Net cash | $9.7M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 850.7% |
| Short % of float | 4.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).